trial

Deep Brain Stimulation for Treatment-Resistant Schizophrenia

NCTId NCT07592611
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Not Yet Recruiting
Enrollment 15 (estimated)
Sponsored by Johns Hopkins University
Primary completion 2029-05-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Not Yet Recruiting
Enrollment
15 (estimated)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2026-08-01
Primary completion
2029-05-30
Eligibility
ALL · 22 Years · 65 Years

Interventions & indications

Drugs
Medtronic Percept with SensSight Deep Brain Stimulation System

Sponsors

Johns Hopkins UniversityLead Sponsor

Investigators

1
Nicola CascellaPrincipal Investigator

Sites

1 total
Baltimore, United States

Facts & assertions

4 sourced
Enrollment
15
Phase
NA
Primary Completion Date
2029-05-30
Status
NOT_YET_RECRUITING
relationships
The graph out of here
drug
Medtronic Percept with SensSight Deep Brain Stimulation System
drug
lead_sponsor
Johns Hopkins University
company
indication
Treatment Resistant Disorders
indication
investigator
Nicola Cascella
person